Clinical Trials Browser

Phase 2/3 × Osteosarcoma × Doxorubicin × Clear all

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Phase 2/3 Recruiting

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT00691236 2011-06-23

ZOL

Phase 2/3 Unknown

Osteosarcoma